JMID yields 0.61% · JNJ yields 3.36%● Live data
📍 JMID pulled ahead of the other in Year 1
Combined, JMID + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JMID + JNJ for your $10,000?
JMID is designed to capitalize on mid-cap growth opportunities within the US market. The portfolio is constructed using a proprietary quantitative model that integrates fundamental research. Security selection focuses on identifying stocks expected to outperform, based on an analysis of various combinations and weightings. The objective is to generate alpha, or returns above the benchmark index, by analyzing key growth factors. Additionally, it employs portfolio optimization techniques to maintain alignment with the benchmark's risk profile. The fund may engage in active and frequent trading.
Full JMID Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.